Classicist, the Romantic and an Uncertain Eternity
Trimarium · 2023
DOI: 10.55159/tri.2023.0103.04 ↗Kurz gefasst
Fachartikel in der Zeitschrift Trimarium, 2023. Verfasst von Józef Maria Ruszar. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
In the second half of the 20th century, the Young Wave of Polish poets (the avant-garde poets born in the mid-1940s) clashed with Zbigniew Herbert (a member of the wartime generation, born around 1920) over generational differences. This dispute revolved around poetics (“plain speech” versus “classicism”) and subject matter: whether poets should deal with “contemporary times” meaning current events, especially focusing on politics, or whether they should rather invoke topoi of Mediterranean culture in order to view current events in the context of the permanent values of European culture. For Herbert, this was also a question of the writing strategy, as he felt that topicality should not dominate the interpretation of the poem and that poetry should survive past communism. Adam Zagajewski was chosen as a representative of the New Wave because his early clash with Herbert propelled him to the position of an adversary. Sadly, both Harbert and Zagajewski failed in their attempt at an exegi monumentum, as the educa- tion system of today has abandoned the classical tradition and many allusions to it are simply incomprehensible to today’s high school or even college graduates. Knowledge of recent history is not in demand either. Both poetics are unintelligible to a wider audience and in this sense they have failed.
Zitieren
APA
Ruszar, J. M. (2023). Classicist, the Romantic and an Uncertain Eternity. Trimarium. https://doi.org/10.55159/tri.2023.0103.04
Vancouver
Ruszar JM. Classicist, the Romantic and an Uncertain Eternity. Trimarium. 2023. doi:10.55159/tri.2023.0103.04
BibTeX
@article{Ruszar2023,
author = {Ruszar, Józef Maria},
title = {Classicist, the Romantic and an Uncertain Eternity},
journal = {Trimarium},
year = {2023},
doi = {10.55159/tri.2023.0103.04}
}
EUVIMED